Recentralization within decentralization: county hospital autonomy under devolution in Kenya EW Barasa, AM Manyara, S Molyneux, B Tsofa PloS one 12 (8), e0182440, 2017 | 112 | 2017 |
A protocol for a multi-site, spatially-referenced household survey in slum settings: methods for access, sampling frame construction, sampling, and field data collection BMC Medical Research Methodology 19, 1-8, 2019 | 32 | 2019 |
Research priorities to reduce the impact of COVID-19 in low-and middle-income countries O Polašek, K Wazny, D Adeloye, P Song, KY Chan, DA Bojude, S Ali, ... Journal of global health 12, 2022 | 18 | 2022 |
Exploring the multidisciplinary extent of public health career structures in 12 countries: an exploratory mapping AM Manyara, C Buunaaisie, H Annett, E Bird, I Bray, J Ige, M Jones, ... Journal of public health 40 (4), e538-e544, 2018 | 18 | 2018 |
Employability and career experiences of international graduates of MSc Public Health: a mixed methods study C Buunaaisie, AM Manyara, H Annett, EL Bird, I Bray, J Ige, M Jones, ... Public health 160, 62-69, 2018 | 12 | 2018 |
Surrogate endpoints in trials—a call for better reporting O Ciani, AM Manyara, RS Taylor bmj 378, 2022 | 8 | 2022 |
Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE AM Manyara, P Davies, D Stewart, CJ Weir, A Young, NJ Butcher, ... BMJ open 12 (10), e064304, 2022 | 7 | 2022 |
Comparison of risk factors between people with type 2 diabetes and matched controls in Nairobi, Kenya A Muchai Manyara, E Mwaniki, CM Gray, JMR Gill Tropical Medicine & International Health, 2021 | 6 | 2021 |
Optimal cut-offs of five anthropometric indices and their predictive ability of type 2 diabetes in a nationally representative Kenyan study AM Manyara AIMS Public Health 8 (3), 507, 2021 | 6 | 2021 |
Need for better reporting of trials with surrogate endpoints: SPIRIT| CONSORT-SURROGATE extensions O Ciani, A Manyara, RS Taylor J Epidemiol Community Health 76 (9), 769-770, 2022 | 5 | 2022 |
Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate endpoints in trials: A scoping review. AM Manyara, P Davies, D Stewart, CJ Weir, AE Young, V Wells, J Blazeby, ... Journal of Clinical Epidemiology, 2023 | 4 | 2023 |
Scoping and targeted reviews to support development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: protocol AM Manyara, P Davies, D Stewart, V Wells, C Weir, A Young, R Taylor, ... BMJ open 12 (10), e062798, 2022 | 4* | 2022 |
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials O Ciani, AM Manyara, P Davies, D Stewart, CJ Weir, AE Young, J Blazeby, ... EClinicalMedicine 65, 2023 | 3 | 2023 |
A call for better reporting of trials using surrogate primary endpoints AM Manyara, O Ciani, RS Taylor Alzheimer's & Dementia: Translational Research & Clinical Interventions 8 (1), 2022 | 3 | 2022 |
Perceptions of diabetes risk and prevention in Nairobi, Kenya: A qualitative and theory of change development study AM Manyara, E Mwaniki, JMR Gill, CM Gray Plos one 19 (2), e0297779, 2024 | 1 | 2024 |
Reply to commentary by cummings (2022): surrogate endpoints extend beyond biomarkers AM Manyara, O Ciani, RS Taylor Alzheimer's and Dementia 8 (1), 2022 | 1 | 2022 |
Surrogate endpoints: a key concept in clinical epidemiology R Christensen, O Ciani, AM Manyara, RS Taylor Journal of Clinical Epidemiology 167, 111242, 2024 | | 2024 |
Knowledge, perceptions and practices towards diabetes risk in sub-Saharan Africa: a mixed-methods scoping review AM Manyara, E Mwaniki, JMR Gill, CM Gray Public Health Nutrition 27 (1), e104, 2024 | | 2024 |
Diabetes research in Kenya from 2000 to 2020: A scoping review AM Manyara, P MUSOTSI | | 2023 |
Surrogate endpoints in trials: a call for better reporting RST Oriana Ciani , Anthony M. Manyara , An‑Wen Chan Trials 23, 991, 2022 | | 2022 |